MA. Ströhlein, MM. Heiss. The trifunctional antibody catumaxomab in treatment of malignant ascites and peritoneal carcinomatosis.. „Future Oncol”. 6 (9), s. 1387-94, Sep 2010. DOI: 10.2217/fon.10.111. PMID: 20919824.
C. Bokemeyer. Catumaxomab--trifunctional anti-EpCAM antibody used to treat malignant ascites.. „Expert Opin Biol Ther”. 10 (8), s. 1259-69, Aug 2010. DOI: 10.1517/14712598.2010.504706. PMID: 20624115.
MA. Ströhlein, MM. Heiss. The trifunctional antibody catumaxomab in treatment of malignant ascites and peritoneal carcinomatosis.. „Future Oncol”. 6 (9), s. 1387-94, Sep 2010. DOI: 10.2217/fon.10.111. PMID: 20919824.
C. Bokemeyer. Catumaxomab--trifunctional anti-EpCAM antibody used to treat malignant ascites.. „Expert Opin Biol Ther”. 10 (8), s. 1259-69, Aug 2010. DOI: 10.1517/14712598.2010.504706. PMID: 20624115.